A 3-year follow-up of temporomandibular disorders in rheumatoid arthritis and ankylosing spondylitis

被引:16
|
作者
Tegelberg, A [1 ]
Kopp, S [1 ]
机构
[1] KAROLINSKA INST,CTR CLIN ORAL SCI,DEPT CLIN ORAL PHYSIOL,STOCKHOLM,SWEDEN
关键词
arthritis; clinical trial; erythrocyte sedimentation rate; orofacial pain; rheumatic disease;
D O I
10.3109/00016359609003503
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Sixteen individuals with rheumatoid arthritis (RA) and 19 individuals with ankylosing spondylitis (AS) participated in this 3-year follow-up study. The individuals in each disease group were allocated to an experimental group (E group) and a comparison group (C group). They were investigated by questionnaire, clinical examination of the stomatognathic system, and laboratory tests. The individuals of the two E groups had performed a physical training program of the stomatognathic system during 3 weeks. After 3 years most of the patients in the E groups reported an unaltered or decreased severity of symptoms and signs from the stomatognathic system compared with the initial status. The clinical dysfunction score according to Helkimo (CDS) was lower in the RA group, and the mouth opening capacity was larger than before training. In the AS group there was no long-term change in the CDS but an increase of mouth opening capacity. The general inflammatory disease process in the RA group showed an increased activity during this follow-up period as assessed by erythrocyte sedimentation rate. This study suggests that local physical training of the stomatognathic system has a positive effect in individuals with RA.
引用
收藏
页码:14 / 18
页数:5
相关论文
共 50 条
  • [41] Mesonephric adenocarcinoma of the vagina with a 3-year follow-up
    Ersahin, Ç
    Huang, M
    Potkul, RK
    Hammadeh, R
    Salhadar, A
    GYNECOLOGIC ONCOLOGY, 2005, 99 (03) : 757 - 760
  • [42] Two-year follow-up of bone density in patients with ankylosing spondylitis.
    Maillefert, JF
    Aho, LS
    El Maghraoui, A
    Dougados, M
    Roux, C
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S267 - S267
  • [43] LOW-DOSE INFLIXIMAB TREATMENT FOR ANKYLOSING SPONDYLITIS: FIVE YEAR FOLLOW-UP
    Sheehy, Claire
    Jois, Ramesh N.
    Leeder, Jane
    Kerrigan, Nicola
    Mills, Karen S.
    Somerville, Margaret
    Scott, David G.
    Gaffney, Karl
    RHEUMATOLOGY, 2011, 50 : 142 - 143
  • [44] Two year follow-up of anterior and vertical atlantoaxial subluxation (AAS) in ankylosing spondylitis (AS).
    RamosRemus, C
    GomezVargas, A
    HernandezChavez, A
    GamezNava, JI
    GonzalezLopez, L
    Russell, AS
    ARTHRITIS AND RHEUMATISM, 1996, 39 (09): : 1074 - 1074
  • [45] Long-term safety and effectiveness of abatacept in Japanese patients with rheumatoid arthritis: 3-year follow-up of a postmarketing surveillance
    Harigai, Masayoshi
    Tsuritani, Katsuki
    Yoshizawa, Yuri
    Atsumi, Tatsuya
    Tanaka, Yoshiya
    MODERN RHEUMATOLOGY, 2022, 32 (03) : 508 - 516
  • [46] Coexistence of rheumatoid arthritis and ankylosing spondylitis
    Borman, Pinar
    Ayhan, Figen
    Okumus, Muyesser
    CLINICAL RHEUMATOLOGY, 2011, 30 (11) : 1517 - 1518
  • [47] Osteoporosis in rheumatoid arthritis and ankylosing spondylitis
    Vosse, D.
    de Vlam, K.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2009, 27 (04) : S62 - S67
  • [48] Treatment of rheumatoid arthritis and ankylosing spondylitis
    Braun, J.
    Sieper, J.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2009, 27 (04) : S146 - S147
  • [49] COEXISTENCE OF ANKYLOSING SPONDYLITIS AND RHEUMATOID ARTHRITIS
    Athanassiou, P.
    Tzanavari, A.
    OSTEOPOROSIS INTERNATIONAL, 2015, 26 : S370 - S371
  • [50] Mortality in rheumatoid arthritis and ankylosing spondylitis
    Zochling, J.
    Braun, J.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2009, 27 (04) : S127 - S130